Qube Research & Technologies (QRT)
IMCR icon

Qube Research & Technologies (QRT)’s Immunocore IMCR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.08M Buy
+223,124
New +$6.6M 0.01% 1458
2025
Q1 		– Sell
-23,015
Closed -$679K – 3668
2024
Q4 		$679K Sell
23,015
-168,526
-88% -$5.33M ﹤0.01% 2341
2024
Q3 		$5.96M Sell
191,541
-60,278
-24% -$2.19M 0.01% 1301
2024
Q2 		$8.53M Buy
251,819
+159,822
+174% +$8.15M 0.01% 990
2024
Q1 		$5.98M Buy
91,997
+33,653
+58% +$2.31M 0.01% 1133
2023
Q4 		$3.99M Sell
58,344
-66,855
-53% -$3.47M 0.01% 1168
2023
Q3 		$6.5M Buy
125,199
+63,232
+102% +$3.74M 0.02% 820
2023
Q2 		$3.72M Sell
61,967
-91,842
-60% -$5.24M 0.01% 797
2023
Q1 		$7.6M Sell
153,809
-11,656
-7% -$655K 0.03% 550
2022
Q4 		$9.44M Buy
+165,465
New +$9.31M 0.05% 507

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IMCR Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Immunocore (IMCR) in Q2 2026: 223,124 shares worth $7.08M. The stake represents 0.01% of the portfolio and ranks #1458 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in IMCR as recently as Q4 2024.

Qube Research & Technologies (QRT) first reported a position in IMCR in Q4 2022 and has held it in 10 quarters since. The position peaked at $9.44M in Q4 2022. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Qube Research & Technologies (QRT) held 223,124 shares of Immunocore worth $7.08M as of Q2 2026.
  • Immunocore was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Immunocore made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1458 holding.
  • Qube Research & Technologies (QRT) first reported a position in Immunocore in Q4 2022 and has held it in 10 quarters since.
  • Qube Research & Technologies (QRT)'s Immunocore position peaked at $9.44M in Q4 2022.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.